Back to search

Article

Comparative study of Revogene GBS LB Assay and GeneXpert GBS LB Assay for the detection of Group B Streptococcus in prenatal screening samples.

2019-12-11

Abstract excerpt

<title>Abstract</title> <p>Background: Group B Streptococcal (GBS) infections in the United States are a leading cause of meningitis and sepsis in newborns. The CDC, therefore recommends GBS screening for all pregnant women at 35–37 weeks of gestation and administration of intrapartum prophylaxis (in those that tested positive) as an effective means of controlling disease transmission. Several FDA approved molecu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
62a74fd1-b9f8-592f-99b1-67090d03583e
DOI
10.21203/rs.2.11661/v5
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative study of Revogene GBS LB Assay and GeneXpert GBS LB Assay for the detection of Group B Streptococcus in prenatal screening samples.DOI 10.21203/rs.2.11661/v5
Select a neighboring publication to make it the new centre.